BTEE.L vs. SBIO.L
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L).
BTEE.L and SBIO.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEE.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Mar 5, 2018. SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014. Both BTEE.L and SBIO.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BTEE.L vs. SBIO.L - Performance Comparison
Loading graphics...
BTEE.L vs. SBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 3.29% | 32.82% | -1.69% | 5.84% | -11.88% | -0.57% | 27.55% | 25.56% | -14.84% |
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 3.46% | 32.89% | -2.00% | 6.14% | -11.85% | -0.49% | 27.35% | 25.54% | -14.62% |
Returns By Period
In the year-to-date period, BTEE.L achieves a 3.29% return, which is significantly lower than SBIO.L's 3.46% return.
BTEE.L
- 1D
- 2.25%
- 1M
- -1.36%
- YTD
- 3.29%
- 6M
- 17.25%
- 1Y
- 39.34%
- 3Y*
- 13.16%
- 5Y*
- 4.62%
- 10Y*
- —
SBIO.L
- 1D
- 2.44%
- 1M
- -1.06%
- YTD
- 3.46%
- 6M
- 17.44%
- 1Y
- 39.73%
- 3Y*
- 13.23%
- 5Y*
- 4.67%
- 10Y*
- 8.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEE.L vs. SBIO.L - Expense Ratio Comparison
BTEE.L has a 0.35% expense ratio, which is lower than SBIO.L's 0.40% expense ratio.
Return for Risk
BTEE.L vs. SBIO.L — Risk / Return Rank
BTEE.L
SBIO.L
BTEE.L vs. SBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BTEE.L | SBIO.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.77 | 1.77 | -0.01 |
Sortino ratioReturn per unit of downside risk | 2.38 | 2.38 | 0.00 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.31 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 3.21 | -0.01 |
Martin ratioReturn relative to average drawdown | 14.39 | 14.30 | +0.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BTEE.L | SBIO.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.77 | 1.77 | -0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.22 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.36 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.27 | +0.04 |
Correlation
The correlation between BTEE.L and SBIO.L is 0.99, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BTEE.L vs. SBIO.L - Dividend Comparison
BTEE.L's dividend yield for the trailing twelve months is around 0.36%, while SBIO.L has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BTEE.L vs. SBIO.L - Drawdown Comparison
The maximum BTEE.L drawdown since its inception was -38.29%, roughly equal to the maximum SBIO.L drawdown of -39.44%. Use the drawdown chart below to compare losses from any high point for BTEE.L and SBIO.L.
Loading graphics...
Drawdown Indicators
| BTEE.L | SBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.29% | -39.44% | +1.15% |
Max Drawdown (1Y)Largest decline over 1 year | -14.02% | -14.07% | +0.05% |
Max Drawdown (5Y)Largest decline over 5 years | -38.29% | -38.33% | +0.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -38.33% | — |
Current DrawdownCurrent decline from peak | -2.70% | -2.55% | -0.15% |
Average DrawdownAverage peak-to-trough decline | -13.78% | -17.03% | +3.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | 2.85% | -0.04% |
Volatility
BTEE.L vs. SBIO.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L) have volatilities of 7.46% and 7.64%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BTEE.L | SBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.46% | 7.64% | -0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 14.21% | 14.10% | +0.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.17% | 22.31% | -0.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.18% | 21.26% | -0.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.50% | 22.28% | +0.22% |